Plain-English translation of NCT06287671 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are studying blood and tissue samples from patients having colorectal surgery to find new biological markers—including special proteins called oncofetal chondroitin sulfate proteoglycans—that could predict serious complications after surgery, detect cancer earlier, and predict which patients are at higher risk for cancer recurrence. The study will follow 1,000 patients at two hospitals in Denmark, collecting blood samples in the days after surgery and during follow-up visits over three years.
Currently, doctors don't have reliable early-warning tests to predict which patients will develop serious complications after colorectal surgery or which patients's cancer will return. This study aims to discover new blood-based markers that could alert doctors to problems sooner and help personalize treatment plans.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have blood samples drawn on each day for the first four days after your surgery, or until you are discharged from the hospital. If you are diagnosed with cancer, you'll have additional blood samples taken 26–35 days after surgery, and then at one, two, and three years with a tissue sample from the tumor. The study team will track your recovery and any complications that develop, and will monitor your long-term health outcomes over the three-year follow-up period.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Denmark